BSE filing, NSE: KSCL. Summary written from the filing by ALFA Finder's alert engine.
Kaveri Seed Company Ltd: key numbers
- Share price
- ₹705.40
- Market cap
- ₹3,629 Cr
- Revenue (annual)
- ₹1,395 Cr
- Net profit (annual)
- ₹295.8 Cr
- P/E (TTM)
- 14.2×Sector 26.8×
- Promoter holding
- 60.50%+0.00% QoQ
- FII holding
- 17.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kaveri Seed Company Ltd
All →Kaveri Seed Company Management Change
Kaveri Seed appointed M. Bhanu Prakash as CFO and KMP effective 28 October 2026. The board also declared a 250% interim dividend and approved eight foreign subsidiaries.
Kaveri Seed Company Dividend
Kaveri Seed Company declared an interim dividend of 250% (₹5 per share) for FY 2026-27. The record date for eligibility is fixed as 6th November 2026.
Kaveri Seed Company Q2 FY27 Results: Net Loss of ₹8.8 Cr, Loss Narrows
Kaveri Seed Company Ltd reported revenue from operations of ₹244.1 Cr (+11.5% YoY) and a net loss of ₹8.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹8.8 Cr
Kaveri Seed Company Other Announcement
Kaveri Seed Company Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI listing regulations.
Kaveri Seed Company Annual General Meeting
Kaveri Seed Company held its 39th AGM on September 29, 2026, approving financial statements, interim dividend ratification, and various director re-appointments.
Kaveri Seed Company Legal & Regulatory
Kaveri Seed disclosed an ITAT hearing notice for a ₹56.21 Crore income-tax appeal filed by the IT Department. The company expects no material adverse impact.
- Value
- ₹56.21 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.